Toor Amit, De Freitas Gerson, Torras Jorge
Internal Medicine Resident, Internal Medicine Department, Easton Hospital, Easton, PA, 18042, USA.
Respir Med Case Rep. 2019 Apr 24;27:100849. doi: 10.1016/j.rmcr.2019.100849. eCollection 2019.
is the second most commonly occurring Non-Tuberculous Mycobacteria (NTM) in the United States. Infection is typically seen in middle aged males, and the risk of infection is greatly increased in immunocompromised hosts. Pulmonary infection presents in clinical parallel to that of (TB) and is therefore often misdiagnosed. A combination of clinical, radiological, and microbiological evidence of infection is generally required to clinch the diagnosis. Treatment of such cases include prolonged courses of rifampin in combination with 2 other antimicrobial agents. The overall prognosis with appropriate treatment is good with the exception of disseminated disease in severely immunocompromised hosts. In patients who are misdiagnosed or undertreated, there is progressive destruction of the lung parenchyma with distortion of lung architecture. This can in-turn lead to bronchiectatic changes leaving the airways exposed to devastating superimposed bacterial pneumonia. We describe a case of a patient with untreated infection who developed superimposed necrotizing pneumonia and respiratory failure requiring prolonged ventilatory support.
是美国第二常见的非结核分枝杆菌(NTM)。感染通常见于中年男性,免疫功能低下的宿主感染风险会大大增加。肺部感染在临床上与肺结核(TB)相似,因此常常被误诊。通常需要结合临床、放射学和微生物学感染证据来确诊。此类病例的治疗包括长时间使用利福平联合其他两种抗菌药物。除了严重免疫功能低下宿主的播散性疾病外,经过适当治疗总体预后良好。在被误诊或治疗不足的患者中,肺实质会逐渐遭到破坏,肺结构变形。这进而会导致支气管扩张性改变,使气道容易遭受毁灭性的叠加细菌性肺炎。我们描述了一例未治疗的[该菌名称]感染患者,其并发了坏死性肺炎和呼吸衰竭,需要长时间的通气支持。 (注:原文中“is the second most commonly occurring Non-Tuberculous Mycobacteria (NTM) in the United States.”中NTM前缺少具体菌名,这里按常规补充了[该菌名称]以便完整理解,实际翻译时应根据准确菌名进行)